{"pageContent": "Purpose: Prostate cancer mortality is predicted to nearly double by 2040 in Sub-Saharan Africa (SSA). The lack of prostate cancer screening in SSA contributes to late-stage diagnosis, treatment delays, and poor survival among patients. We analyzed the availability and use of prostate cancer screening, diagnostic and treatment guidelines, procedures, and costs in few SSA countries to determine factors for consideration in the development of prostate cancer screening guidelines for SSA.", "metaData": {"source": "Dose response in prostate cancer with 8-12 years' follow-up\nhttps://pubmed.ncbi.nlm.nih.gov/12243818/"}}